From a heterogeneity standpoint, varied expression of lung adenocarcinoma markers, EMT, and tumor vasculature was observed across six different regions of the same tumor, suggesting that a single tumor biopsy would not provide a holistic assessment of this particular ALK‐rearranged cancer. The gene discussed is ALK; the disease is lung adenocarcinoma.